Stoke Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Stoke Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 3, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NASDAQ
DEFA14A: Stoke Therapeutics Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Stoke Therapeutics has scheduled its annual stockholder meeting for June 3, 2025, outlining proposals including the election of directors, ratification of the auditor, and executive compensation.
NASDAQ
Stoke Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 3, 2025, outlining proposals for director elections, auditor ratification, and executive compensation.
NASDAQ
Stoke Therapeutics has scheduled its annual shareholder meeting for June 5, 2024, with key proposals including the election of Class II directors and ratification of KPMG LLP as the independent auditor.
NASDAQ
Stoke Therapeutics is holding its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, to elect directors and ratify the appointment of its independent auditor.